Literature DB >> 28097378

[Molecular pathogenesis of Duchenne muscular dystrophy-related fibrosis].

K Ohlendieck1, D Swandulla2.   

Abstract

Progressive myofibrosis plays a key role in Duchenne muscular dystrophy. The dystrophic loss of contractile cells triggers a relatively nonspecific restructuring of the surrounding mesenchyme. The increase in connective and fatty tissue leads to muscular weakness and is therefore of critical importance for the cellular pathogenesis of muscular dystrophy. The systematic biochemical analysis of fibrosis using comparative proteomics has identified a number of extracellular matrix proteins that are indirectly involved in muscular dystrophy. An increased concentration was established for collagen I, collagen IV, collagen VI, periostin, dermatopontin, fibronectin, biglycan, asporin, decorin, prolargin, mimecan and lumican. Based on these findings, the identified matrix proteins can now be characterized biochemically and their exact pathophysiological role in Duchenne muscular dystrophy determined.

Entities:  

Keywords:  Collagen; Dystrophin; Muscle proteome; Myofibrosis; Periostin

Mesh:

Substances:

Year:  2017        PMID: 28097378     DOI: 10.1007/s00292-017-0265-1

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  28 in total

Review 1.  Defining the extracellular matrix using proteomics.

Authors:  Adam Byron; Jonathan D Humphries; Martin J Humphries
Journal:  Int J Exp Pathol       Date:  2013-02-19       Impact factor: 1.925

2.  Label-free mass spectrometric analysis of the mdx-4cv diaphragm identifies the matricellular protein periostin as a potential factor involved in dystrophinopathy-related fibrosis.

Authors:  Ashling Holland; Paul Dowling; Paula Meleady; Michael Henry; Margit Zweyer; Rustam R Mundegar; Dieter Swandulla; Kay Ohlendieck
Journal:  Proteomics       Date:  2015-04-01       Impact factor: 3.984

3.  Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice.

Authors:  D Gardan-Salmon; J M Dixon; S M Lonergan; J T Selsby
Journal:  Eur J Appl Physiol       Date:  2011-03-16       Impact factor: 3.078

4.  Connective tissue growth factor is overexpressed in muscles of human muscular dystrophy.

Authors:  Guilian Sun; Kazuhiro Haginoya; Yanling Wu; Yoko Chiba; Tohru Nakanishi; Akira Onuma; Yuko Sato; Masaharu Takigawa; Kazuie Iinuma; Shigeru Tsuchiya
Journal:  J Neurol Sci       Date:  2007-11-09       Impact factor: 3.181

5.  β-Sarcoglycan gene transfer decreases fibrosis and restores force in LGMD2E mice.

Authors:  E R Pozsgai; D A Griffin; K N Heller; J R Mendell; L R Rodino-Klapac
Journal:  Gene Ther       Date:  2015-08-20       Impact factor: 5.250

6.  Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation.

Authors:  Isabelle Desguerre; Michelle Mayer; France Leturcq; Jacques-Patrick Barbet; Romain K Gherardi; Christo Christov
Journal:  J Neuropathol Exp Neurol       Date:  2009-07       Impact factor: 3.685

Review 7.  Duchenne and Becker muscular dystrophies.

Authors:  Kevin M Flanigan
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

Review 8.  The extracellular matrix: Tools and insights for the "omics" era.

Authors:  Alexandra Naba; Karl R Clauser; Huiming Ding; Charles A Whittaker; Steven A Carr; Richard O Hynes
Journal:  Matrix Biol       Date:  2015-07-08       Impact factor: 11.583

9.  Fibronectin is a serum biomarker for Duchenne muscular dystrophy.

Authors:  F Cynthia Martin; Monika Hiller; Pietro Spitali; Stijn Oonk; Hans Dalebout; Magnus Palmblad; Amina Chaouch; Michela Guglieri; Volker Straub; Hanns Lochmüller; Erik H Niks; Jan J G M Verschuuren; Annemieke Aartsma-Rus; André M Deelder; Yuri E M van der Burgt; Peter A C 't Hoen
Journal:  Proteomics Clin Appl       Date:  2014-03-11       Impact factor: 3.494

10.  Application of fluorescence two-dimensional difference in-gel electrophoresis as a proteomic biomarker discovery tool in muscular dystrophy research.

Authors:  Steven Carberry; Margit Zweyer; Dieter Swandulla; Kay Ohlendieck
Journal:  Biology (Basel)       Date:  2013-12-02
View more
  10 in total

1.  Proteomic profiling of the mouse diaphragm and refined mass spectrometric analysis of the dystrophic phenotype.

Authors:  Sandra Murphy; Margit Zweyer; Maren Raucamp; Michael Henry; Paula Meleady; Dieter Swandulla; Kay Ohlendieck
Journal:  J Muscle Res Cell Motil       Date:  2019-03-19       Impact factor: 2.698

2.  Proteomic profiling of the dystrophin complex and membrane fraction from dystrophic mdx muscle reveals decreases in the cytolinker desmoglein and increases in the extracellular matrix stabilizers biglycan and fibronectin.

Authors:  Sandra Murphy; Heinrich Brinkmeier; Mirjam Krautwald; Michael Henry; Paula Meleady; Kay Ohlendieck
Journal:  J Muscle Res Cell Motil       Date:  2017-08-12       Impact factor: 2.698

Review 3.  Complexity of skeletal muscle degeneration: multi-systems pathophysiology and organ crosstalk in dystrophinopathy.

Authors:  Kay Ohlendieck; Dieter Swandulla
Journal:  Pflugers Arch       Date:  2021-09-22       Impact factor: 4.458

Review 4.  Histopathology of Duchenne muscular dystrophy in correlation with changes in proteomic biomarkers.

Authors:  Margit Zweyer; Hemmen Sabir; Paul Dowling; Stephen Gargan; Sandra Murphy; Dieter Swandulla; Kay Ohlendieck
Journal:  Histol Histopathol       Date:  2021-12-07       Impact factor: 2.303

5.  Chemical crosslinking analysis of β-dystroglycan in dystrophin-deficient skeletal muscle.

Authors:  Sandra Murphy; Margit Zweyer; Rustam R Mundegar; Dieter Swandulla; Kay Ohlendieck
Journal:  HRB Open Res       Date:  2018-09-17

6.  Proteomic identification of elevated saliva kallikrein levels in the mdx-4cv mouse model of Duchenne muscular dystrophy.

Authors:  Sandra Murphy; Margit Zweyer; Rustam R Mundegar; Dieter Swandulla; Kay Ohlendieck
Journal:  Biochem Biophys Rep       Date:  2018-05-30

7.  miR-29a is a potential protective factor for fibrogenesis in gluteal muscle contracture.

Authors:  R Zhou; S Ren; C Li; X Zhang; W Zhang
Journal:  Physiol Res       Date:  2020-05-29       Impact factor: 1.881

8.  Mass spectrometric identification of dystrophin, the protein product of the Duchenne muscular dystrophy gene, in distinct muscle surface membranes.

Authors:  Sandra Murphy; Kay Ohlendieck
Journal:  Int J Mol Med       Date:  2017-07-27       Impact factor: 4.101

9.  Proteomic profiling of liver tissue from the mdx-4cv mouse model of Duchenne muscular dystrophy.

Authors:  Sandra Murphy; Margit Zweyer; Michael Henry; Paula Meleady; Rustam R Mundegar; Dieter Swandulla; Kay Ohlendieck
Journal:  Clin Proteomics       Date:  2018-10-29       Impact factor: 3.988

10.  Mass Spectrometric Profiling of Extraocular Muscle and Proteomic Adaptations in the mdx-4cv Model of Duchenne Muscular Dystrophy.

Authors:  Stephen Gargan; Paul Dowling; Margit Zweyer; Jens Reimann; Michael Henry; Paula Meleady; Dieter Swandulla; Kay Ohlendieck
Journal:  Life (Basel)       Date:  2021-06-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.